Pandemic drives big data in healthcare to $70B by 2025 – PCR pcr-online.biz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pcr-online.biz Daily Mail and Mail on Sunday newspapers.
Modern Diplomacy
Published 1 day ago
The European Commission is today complementing the successful EU Vaccines Strategy with a strategy on COVID-19 therapeutics to support the development and availability of much-needed COVID-19 therapeutics, including for the treatment of ‘long COVID’. Today’s Strategy covers the full lifecycle of medicines: from research, development and manufacturing to procurement and deployment.
It is part of the strong European Health Union, in which all EU countries prepare and respond together to health crises and ensure the availability of affordable and innovative medical supplies – including the therapeutics needed to treat COVID-19.
The Strategy includes clear actions and targets, including authorising three new therapeutics to treat COVID-19 by October 2021 and possibly two more by end of the year. Concretely:
EAPM: Stronger together against cancer and with good data sharing eureporter.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eureporter.co Daily Mail and Mail on Sunday newspapers.
Note From the Editors
The pace of impact through digital health in 2021 is off to a rapid start be it the number of transactions, the numerous legislative proposals and actions, or the focused attention of enforcement bodies. Given the accelerated pace of tech-enabled methods, such as telehealth or product development through streamlined digital tools and decentralized clinical trials, not to mention AI and big data s impact on diagnostic and research capacity, the policy and regulatory spotlight on digital health will no doubt be bright throughout this year. In the Industry Insights contribution for this issue, several of our digital health experts briefly summarize the focused attention of U.S. enforcement agencies on telehealth given significantly increased reimbursement trends in the area.
Note From the Editors
The pace of impact through digital health in 2021 is off to a
rapid start be it the number of transactions, the numerous
legislative proposals and actions, or the focused attention of
enforcement bodies. Given the accelerated pace of tech-enabled
methods, such as telehealth or product development through
streamlined digital tools and decentralized clinical trials, not to
mention AI and big data s impact on diagnostic and research
capacity, the policy and regulatory spotlight on digital health
will no doubt be bright throughout this year. In the Industry
Insights contribution for this issue, several of our digital
health experts briefly summarize the focused attention of U.S.